Patent · US Active

HDAC6 selective inhibitors, preparation method therefor, and application thereof

US10745389B2 · kind B2 · utility

3Cited by

0References

17Claims

0Family size

Assignees

CSTONE PHARMACEUTICALS (SUZHOU) CO., LTD. · CN
CSTONE PHARMACEUTICALS (SHANGHAI) CO., LTD. · CN
CSTONE PHARMACEUTICALS · KY

Inventors

Hao Wu · Shanghai, CN
Changqing Wei · Shanghai, CN
Qiang Guo · Tangxia, CN
Guifen Zhang · Wallingford, US
Bin Liu · Fishers, US
Yonggang Liao · Shanghai, CN
Yao Xiao · Sundsberg, FI
Shuhui CHEN · Shanghai, CN

Key dates

Filing date	Jan 10, 2018
Grant date	Aug 18, 2020
Priority date	—
Expiry date	Jan 10, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D405/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compounds serving as histone deacetylase 6 (HDAC6) selective inhibitors, and applications thereof in the preparation of drugs for treating HDAC6-related diseases. Specifically disclosed are a compound as represented by formula (I) and a pharmaceutically acceptable salt thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.